BackHCW Biologics Overview

HCW Biologics Receivables

Track HCW Biologics's receivables ($75K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$74844.00
↓ 14.46% YoYΔ $-12649.00 vs prior year quarter

Peer average

Loading

HCW Biologics Receivables History

Loading

HCW Biologics vs. peers: Receivables Comparison

Loading

HCW Biologics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

HCW Biologics (HCWB) FAQ

The latest receivables for HCWB is $75K as of March 2026. That compares with $87K in the prior-year period — down 14.5% year over year. Investors often review this figure alongside HCW Biologics's historical trend and sector peers before judging valuation or financial health.

Over the past year, HCWB's receivables moved from $87K to $75K — a 14.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in HCW Biologics's operating scale or balance-sheet position.

A receivables figure of $75K for HCWB is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting HCWB's receivables ($75K), review year-over-year change from $87K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack HCW Biologics's receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.